Abacus Medicine A/S

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2022

In its 2023 reporting, Abacus Medicine A/S disclosed greenhouse gas emissions of 855.5 tCO2e (Scope 1 & 2). By scope: Scope 1: 216.9 tCO2e; Scope 2: 632.9 tCO2e (location-based). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
855.5 tCO2e (Scope 1 & 2)
2023
⚡
Renewable Energy
31%
of total energy
♻️
Waste
192 tons (Paper and Cardboard)
2023
⚙️
Energy Use
2.4M kWh
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).216.9 tCO2e
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.632.9 tCO2e (location-based)

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2023855.5 tCO2e (Scope 1 & 2)
2022814.7 tCO2e (Scope 1 & 2)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🌱 ESG Focus Areas

Good Health and Well-being (SDG 3)Decent work and Economic Growth (SDG 8)Responsible Consumption and Production (SDG 12)Diversity & InclusionEnvironmental Impact (Transportation and Waste)Governance (Compliance and Ethics)

⚠️ Challenges & Risks +

  • Medicine shortages in several European countries due to various factors (production capacity, distribution, compliance delays, market prioritization by manufacturers).
  • Environmental impact from transportation and repackaging of medicine.
  • Maintaining collaboration and internal communication with rapid growth.

📋 Report Information

Reporting Period: 2023